MDWD insider trading

NasdaqGM Healthcare

MediWound Ltd.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
11
Last 90 days
5
Buys / sells
64% / 36%
Market cap
$184.17M

About MediWound Ltd.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Company website: www.mediwound.com

MDWD insider activity at a glance

FilingIQ tracks 11 insider transactions for MDWD in filings since Jun 1, 2026. The most recent transaction is dated Sep 1, 2026.

Across the full history, 7 open-market purchases and 4 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest MDWD Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Other Healthcare tickers with recent insider activity

13F funds holding MDWD

Frequently asked

How many insider trades does FilingIQ track for MDWD?
FilingIQ tracks 11 Form 4 insider transactions for MDWD (MediWound Ltd.), covering filings from Jun 1, 2026 onwards. 5 of those are dated within the last 90 days.
Are MDWD insiders net buyers or net sellers?
Across the full Form 4 history for MDWD, 7 transactions (64%) were open-market purchases and 4 (36%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MDWD insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
What sector is MDWD in?
MediWound Ltd. (MDWD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $184.17M.

Methodology & sources

Every MDWD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.